Evidence map›Paper›PMID 26135329›Full record

ArticleInternational journal of cancer2015

Body iron status and gastric cancer risk in the EURGAST study.

Ana Fonseca-Nunes, Antonio Agudo, Núria Aranda, Victoria Arija, Amanda J Cross, Esther Molina, Maria Jose Sanchez, H B As Bueno-de-Mesquita, Peter Siersema, Elisabete Weiderpass and 33 more

Open access · bronzeAbstract read
In one paragraph

Article in International journal of cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Heavy metals in biological samples of cancer patients: a systematic literature review.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2024
    Pooled it
  3. Article
  4. Article
  5. Targeting ferroptosis inInternational journal of oncology · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

43 authors at 20 institutions in 12 countries.

Ana Fonseca-NunesUnit of Nutrition and Cancer, Catalan Institute of Oncology-ICO, IDIBELL, L'Hospitalet De Llobregat, Barcelona, Spain.
Antonio AgudoUnit of Nutrition and Cancer, Catalan Institute of Oncology-ICO, IDIBELL, L'Hospitalet De Llobregat, Barcelona, Spain.
Núria ArandaIISPV, Departament De Ciències Mèdiques Bàsiques, Universitat Rovira I Virgili (URV), Tarragona, Spain.
Victoria ArijaIISPV, Departament De Ciències Mèdiques Bàsiques, Universitat Rovira I Virgili (URV), Tarragona, Spain.
Amanda J CrossDepartment of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, Imperial College London, London, United Kingdom.
Esther MolinaEscuela Andaluza De Salud Pública, Instituto De Investigación Biosanitaria Ibs.GRANADA, Hospitales Universitarios De Granada/Universidad De Granada, Granada, Spain.
Maria Jose SanchezEscuela Andaluza De Salud Pública, Instituto De Investigación Biosanitaria Ibs.GRANADA, Hospitales Universitarios De Granada/Universidad De Granada, Granada, Spain.
H B As Bueno-de-MesquitaDepartment of Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Peter SiersemaDepartment of Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Elisabete WeiderpassDepartment of Community Medicine, Faculty of Health Sciences, University of Tromsø, the Arctic University of Norway, Tromsø, Norway.
Vittorio KroghEpidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milano, Italy.
Amalia MattielloDipartamento Di Medicina Clinica E Chirugia, Federico II University, Naples, Italy.
Rosario TuminoCancer Registry and Histopathology Unit, "Civic - M.P.Arezzo" Hospital, ASP Ragusa, Italy.
Calogero SaievaMolecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy.
Alessio NaccaratiMolecular and Genetic Epidemiology Unit, HuGeF - Human Genetics Foundation - Torino, Torino, Italy.
Bodil OhlssonDepartment of Clinical Sciences, Division of Internal Medicine, Skåne University Hospital Malmo, Lund University, Malmo, Sweden.
Klas SjöbergDepartment of Clinical Sciences, Division of Internal Medicine, Skåne University Hospital Malmo, Lund University, Malmo, Sweden.
Marie-Christine Boutron-RuaultInserm, Centre for Research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones and Women's Health Team, Villejuif, France.
Claire CadeauInserm, Centre for Research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones and Women's Health Team, Villejuif, France.
Guy FagherazziInserm, Centre for Research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones and Women's Health Team, Villejuif, France.
Heiner BoeingDepartment of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Nuthetal, Germany.
Annika SteffenDepartment of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Nuthetal, Germany.
Tilman KühnDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Verena KatzkeDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Anne TjønnelandDanish Cancer Society Research Center, Copenhagen, Denmark.
Anja OlsenDanish Cancer Society Research Center, Copenhagen, Denmark.
Kay-Tee KhawMRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Nick WarehamMRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Tim KeyCancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
Yunxia LuDepartment of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, Imperial College London, London, United Kingdom.
Elio RiboliDepartment of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, Imperial College London, London, United Kingdom.
Petra H PeetersDepartment of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Diana GavrilaCIBER De Epidemiología Y Salud Pública (CIBERESP), Madrid, Spain.
Miren DorronsoroBasque Regional Health Department, Public Health Direction and Biodonostia-Ciberesp, San Sebastian, Spain.
José Ramón QuirósPublic Health Directorate, Asturias, Spain.
Aurelio BarricarteNavarre Public Health Institute, Pamplona, Spain.
Mazda JenabInternational Agency for Research on Cancer (IARC-WHO), Lyon, France.
Raúl Zamora-RosInternational Agency for Research on Cancer (IARC-WHO), Lyon, France.
Heinz FreislingInternational Agency for Research on Cancer (IARC-WHO), Lyon, France.
Antonia TrichopoulouWHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece.
Pagona LagiouWHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece.
Christina BamiaWHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece.
Paula JakszynUnit of Nutrition and Cancer, Catalan Institute of Oncology-ICO, IDIBELL, L'Hospitalet De Llobregat, Barcelona, Spain.
Centre International de Recherche sur le Cancer · FRCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESImperial College London · GBDanish Cancer Society · DKGerman Institute of Human Nutrition · DEHeidelberg University · DEHellenic Health Foundation · GRInstitut d'Investigació Biomédica de Bellvitge · ESAzienda Usl 8 Arezzo · ITBiogipuzkoa Health Research Institute · ESCancer Registry of Norway · NOCentre de recherche en Epidémiologie et Santé des Populations · FRFederico II University Hospital · ITFondazione IRCCS Istituto Nazionale dei Tumori · ITGobierno del Principado de Asturias · ESInserm · FRInstitut Català d'Oncologia · ESInstitut d'Investigació Sanitària Pere Virgili · ESItalian institute for Genomic Medicine · ITLund University · SE

Funding

Cancer Research UK 14136Cancer Research UK 16491Medical Research Council G0401527Medical Research Council G1000143Medical Research Council MC_U106179471Medical Research Council MC_UU_12015/1World Health Organization 001
6 · The paper itself

Abstract

Although it appears biologically plausible for iron to be associated with gastric carcinogenesis, the evidence is insufficient to lead to any conclusions. To further investigate the relationship between body iron status and gastric cancer risk, we conducted a nested case-control study in the multicentric European Prospective Investigation into Cancer and Nutrition (EPIC) study. The study included 456 primary incident gastric adenocarcinoma cases and 900 matched controls that occurred during an average of 11 years of follow-up. We measured prediagnostic serum iron, ferritin, transferrin and C-reactive protein, and further estimated total iron-binding capacity (TIBC) and transferrin saturation (TS). Odds ratios (ORs) and 95% confidence intervals (CIs) for the risk of gastric cancer by iron metrics were estimated from multivariable conditional logistic regression models. After adjusting for relevant confounders, we observed a statistically significant inverse association between gastric cancer and ferritin and TS indices (ORlog2  = 0.80, 95% CI = 0.72-0.88; OR10%increment  = 0.87, 95% CI = 0.78-0.97, respectively). These associations appear to be restricted to noncardia gastric cancer (ferritin showed a p for heterogeneity = 0.04 and TS had a p for heterogeneity = 0.02), and no differences were found by histological type. TIBC increased risk of overall gastric cancer (OR50 µg/dl  = 1.13, 95% CI = 1.02-1.2) and also with noncardia gastric cancer (p for heterogeneity = 0.04). Additional analysis suggests that time between blood draw and gastric cancer diagnosis could modify these findings. In conclusion, our results showed a decreased risk of gastric cancer related to higher body iron stores as measured by serum iron and ferritin. Further investigation is needed to clarify the role of iron in gastric carcinogenesis.

Indexed as

AdenocarcinomaCase-Control StudiesFerritinsHumansIronRisk FactorsStomach NeoplasmsFerritinsIrongastric canceriron homeostasisnested case-control study

Identifiers

PMID26135329
PMCPMC6284801
OpenAlexW2157425804

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.